Mineralys Therapeutics, Inc. (MLYS) NASDAQ

15.34

+0.82(+5.65%)

Updated at August 18 04:00PM

Currency In USD

Valuation

Market Cap597.52M
Enterprise Value483.42M
P/E Ratio-5.26
PEG Ratio-1.15
Price/Sales Ratio29,910.83
Price/Book Ratio3.2
Enterprise/Revenue26,917.06
Enterprise/EBITDA-4.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-5,610.97
Operating Margin-5,972.53

Management Effectiveness

Return On Assets-0.57
Return On Equity-0.7

Income Statement

Revenue0
Revenue/Share0
Gross Profit-43,000
EBITDA-192.36M
Net Income-177.81M
Diluted EPS-3.66

Balance Sheet

Total Cash101.79M
Total Cash/Share1.56
Total Debt0
Total Debt/Equity0
Current Ratio15.12
Book Value Per Share4.79

Price History

52-Week Change44.44
52-Week High18.38
52-Week Low8.24
Moving Average 50 Days14.12
Moving Average 200 Days13.13

Statistics

Average Volume817,229.6
Shares Outstanding66.3M
% Held by Institutions100.34

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A